Journal Article10.1111/XEN.12321
Cytokine profiles in Tibetan macaques following α-1,3-galactosyltransferase-knockout pig liver xenotransplantation.
Zhuochao Zhang,Xiao Li,Hong Zhang,Xuan Zhang,Hui Chen,Dengke Pan,Hongchen Ji,Liang Zhou,Juan Ling,Jingshi Zhou,Shuqiang Yue,Desheng Wang,Zhaoxu Yang,Kaishan Tao,Kefeng Dou +14 more
21
TL;DR: This work utilized a modified heterotopic auxiliary liver xenotransplantation model for xeno‐immunological research to better elucidate the process of inflammation in liver xenograft recipients.
read more
Abstract: Background
Pig-to-nonhuman primate orthotopic liver xenotransplantation is often accompanied by thrombocytopenia and coagulation disorders. Furthermore, the release of cytokines can trigger cascade reactions of coagulation and immune attacks within transplant recipients. To better elucidate the process of inflammation in liver xenograft recipients, we utilized a modified heterotopic auxiliary liver xenotransplantation model for xeno-immunological research. We studied the cytokine profiles and the relationship between cytokine levels and xenograft function after liver xenotransplantation.
Methods
Appropriate donor and recipient matches were screened using complement-dependent cytotoxicity assays. Donor liver grafts from α1,3-galactosyltransferase gene-knockout (GTKO) pigs or GTKO pigs additionally transgenic for human CD47 (GTKO/CD47) were transplanted into Tibetan macaques via two different heterotrophic auxiliary liver xenotransplantation procedures. The cytokine profiles, hepatic function, and coagulation parameters were monitored during the clinical course of xenotransplantation.
Results
Xenograft blood flow was stable in recipients after heterotopic auxiliary transplantation. A Doppler examination indicated that the blood flow speed was faster in the hepatic artery (HA) and hepatic vein (HV) of xenografts subjected to the modified Sur II (HA-abdominal aorta+HV-inferior vena cava) procedure than in those subjected to our previously reported Sur I (HA-splenic artery+HV-left renal vein) procedure. Tibetan macaques receiving liver xenografts did not exhibit severe coagulation disorders or immune rejection. Although the recipients did suffer from a rapid loss of platelets, this loss was mild. In blood samples dynamically collected after xenotransplantation (post-Tx), dramatic increases in the levels of monocyte chemoattractant protein 1, interleukin (IL)-8, granulocyte-macrophage colony-stimulating factor, IL-6, and interferon gamma-induced protein 10 were observed at 1 hour post-Tx, even under immunosuppression. We further confirmed that the elevation in individual cytokine levels was correlated with the onset of graft damage. Finally, the release of cytokines might contribute to leukocyte infiltration in the xenografts.
Conclusion
Here, we established a modified auxiliary liver xenotransplantation model resulting in near-normal hepatic function. Inflammatory cytokines might contribute to early damage in liver xenografts. Controlling the systemic inflammatory response of recipients might prevent early post-Tx graft dysfunction.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Potential pathological role of pro-inflammatory cytokines (IL-6, TNF-α, and IL-17) in xenotransplantation.
Yanli Zhao,David K. C. Cooper,Huiyun Wang,Chen Pengfei,Chen He,Zhiming Cai,Lisha Mou,Shaodong Luan,Gao Hanchao +8 more
TL;DR: It was found that IL‐6, TNF‐α, and IL‐17 were induced in most in vitro or in vivo xenotransplantation model and blocked two or even more cytokines together might get better effect in suppressing xenograft rejection.
41
A review of pig liver xenotransplantation: Current problems and recent progress
Xuan Zhang,Xiao Li,Zhaoxu Yang,Kai-shan Tao,Quancheng Wang,Bin Dai,Shibin Qu,Wei Peng,Hong Zhang,David K. C. Cooper,Ke-Feng Dou +10 more
TL;DR: Clinical trials of pig liver xenotransplantation should initially be considered as a bridge to allotransplantations, with the aim of identifying the ideal transgene combination for pig liver Xenotrans transplantation.
38
Decellularized xenografts in regenerative medicine: From processing to clinical application
TL;DR: The authors provide an overview of the different sources and processing methods used in decellularized xenografts fabrication and discuss their effect on the clinical performance of commercially available deCellularized Xenograft.
37
Current status of xenotransplantation research and the strategies for preventing xenograft rejection
TL;DR: This review comprehensively discussed the mechanism of these immunological rejections and summarized the strategies for preventing them, such as generation of gene knock out donors by different genome editing tools and the use of immunosuppressive regimens.
Genetic engineering of pigs for xenotransplantation to overcome immune rejection and physiological incompatibilities: The first clinical steps
TL;DR: In this article , a review of genetically modified pigs and comprehensively summarize the immunological mechanism of xenograft rejection and recent progress in preclinical and clinical studies is presented. And the authors conclude that both genetically engineered pig-based and technological breakthroughs in the biomedical field provide a promising foundation for pig-to-human xenotransplantation in the future.
References
Clinical xenotransplantation: the next medical revolution?
Burcin Ekser,Mohamed Ezzelarab,Hidetaka Hara,Dirk J. van der Windt,Dirk J. van der Windt,Dirk J. van der Windt,Martin Wijkstrom,Rita Bottino,Massimo Trucco,David K. C. Cooper +9 more
TL;DR: Results of preclinical transplantation of pig cells--eg, islets, neuronal cells, hepatocytes, or corneas--are much more encouraging than they are for organ transplantation, with survival times greater than 1 year in all cases.
368
Liver transplantation: Current status and challenges
TL;DR: Improved understanding of the pathophysiology of liver allografts procured after circulatory arrest has not only resulted in better selection and management of DCD donors, but has also helped in the development of mechanical perfusion strategies.
272
Pig kidney graft survival in a baboon for 136 days: longest life‐supporting organ graft survival to date
Hayato Iwase,Hong Liu,Hong Liu,Martin Wijkstrom,Huidong Zhou,Huidong Zhou,Jagjit Singh,Hidetaka Hara,Mohamed Ezzelarab,Cassandra Long,Edwin Klein,Robert Wagner,Carol Phelps,David Ayares,Ron Shapiro,Abhinav Humar,David K. C. Cooper +16 more
TL;DR: The combination of a graft from a specific genetically engineered pig, an effective immunosuppressive regimen, and anti‐inflammatory agents prevented immune injury and a protein‐losing nephropathy, and delayed coagulation dysfunction encourages us that clinical renal xenotransplantation may become a reality.
Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from α1,3-galactosyltransferase gene-knockout pigs in baboons
Akira Shimizu,Yosuke Hisashi,Kenji Kuwaki,Yau Lin Tseng,Frank J. M. F. Dor,Stuart L. Houser,Simon C. Robson,Henk Jan Schuurman,David K. C. Cooper,David H. Sachs,Kazuhiko Yamada,Robert B. Colvin +11 more
TL;DR: Although the use of GalT-KO swine donors prevented hyperacute rejection and prolonged graft survival, slowly progressive humoral rejection--probably associated with non-Gal antibodies to the xenograft--and disordered thromboregulation represent major immunological barriers to long-term Xenograft survival.
Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: clinical relevance.
Burcin Ekser,Burcin Ekser,Cassandra Long,Gabriel J. Echeverri,Hidetaka Hara,Mohamed Ezzelarab,Chih Che Lin,M. E. de Vera,Robert Wagner,Edwin Klein,Roman F. Wolf,D. Ayares,David K. C. Cooper,Bruno Gridelli,Bruno Gridelli +14 more
TL;DR: It is anticipated that a pig liver could provide a period during which a patient in liver failure could be successfully bridged to allotransplantation.
119